269 related articles for article (PubMed ID: 25526485)
1. Interaction between angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on survival in hemodialyzed patients.
Kiss I; Ambrus C; Kulcsár I; Szegedi J; Kerkovits L; Tislér A; Kiss Z;
Medicine (Baltimore); 2014 Dec; 93(28):e315. PubMed ID: 25526485
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and survival in a cohort of chronic hemodialysis patients.
Higashiuesato Y; Tana T; Tozawa M; Iseki C; Iseki K; Fukiyama K; Takishita S
Clin Nephrol; 2002 Nov; 58(5):370-5. PubMed ID: 12425488
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism.
So WY; Ma RC; Ozaki R; Tong PC; Ng MC; Ho CS; Lam CW; Chow CC; Chan WB; Kong AP; Chan JC
Kidney Int; 2006 Apr; 69(8):1438-43. PubMed ID: 16395257
[TBL] [Abstract][Full Text] [Related]
4. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
[TBL] [Abstract][Full Text] [Related]
5. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
O'Toole L; Stewart M; Padfield P; Channer K
J Cardiovasc Pharmacol; 1998 Dec; 32(6):988-94. PubMed ID: 9869506
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
Vegter S; Perna A; Hiddema W; Ruggenenti P; Remuzzi G; Navis G; Postma MJ
Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.
van der Knaap R; Siemes C; Coebergh JW; van Duijn CM; Hofman A; Stricker BH
Cancer; 2008 Feb; 112(4):748-57. PubMed ID: 18181094
[TBL] [Abstract][Full Text] [Related]
8. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
[TBL] [Abstract][Full Text] [Related]
9. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
[TBL] [Abstract][Full Text] [Related]
10. Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism.
Bleumink GS; Schut AF; Sturkenboom MC; van Duijn CM; Deckers JW; Hofman A; Kingma JH; Witteman JC; Stricker BH
Pharmacogenet Genomics; 2005 Feb; 15(2):75-81. PubMed ID: 15861031
[TBL] [Abstract][Full Text] [Related]
11. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype.
Cicoira M; Zanolla L; Rossi A; Golia G; Franceschini L; Cabrini G; Bonizzato A; Graziani M; Anker SD; Coats AJ; Zardini P
J Am Coll Cardiol; 2001 Jun; 37(7):1808-12. PubMed ID: 11401115
[TBL] [Abstract][Full Text] [Related]
12. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
[TBL] [Abstract][Full Text] [Related]
13. ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis.
van der Sman-de Beer F; Verhagen C; Rombach SM; Boorsma P; van Manen JG; Korevaar JC; van den Bogaard R; Boeschoten EW; Krediet RT; Navis GJ; Vandenbroucke JP; Dekker FW;
Kidney Int; 2005 Nov; 68(5):2237-43. PubMed ID: 16221224
[TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on erythropoiesis in patients on haemodialysis.
Kiss Z; Ambrus C; Kulcsár I; Szegedi J; Kiss I; ;
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1021-7. PubMed ID: 25002133
[TBL] [Abstract][Full Text] [Related]
15. The functional angiotensin converting enzyme gene I/D polymorphism does not alter susceptibility to chronic pancreatitis.
Oruc N; Lamb J; Kutlu OC; Barmada MM; Money ME; Slivka A; Whitcomb DC
JOP; 2004 Nov; 5(6):457-63. PubMed ID: 15536282
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of the angiotensin-converting enzyme gene in end-stage renal failure patients.
Aucella F; Vigilante M; Margaglione M; Grandone E; del Popolo A; Forcella M; Procaccini D; Salatino G; Passione A; Ktena M; De Min A; Stallone C
Nephron; 2000 May; 85(1):54-9. PubMed ID: 10773756
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
McNamara DM; Holubkov R; Janosko K; Palmer A; Wang JJ; MacGowan GA; Murali S; Rosenblum WD; London B; Feldman AM
Circulation; 2001 Mar; 103(12):1644-8. PubMed ID: 11273991
[TBL] [Abstract][Full Text] [Related]
19. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.
Pérez-Oller L; Torra R; Badenas C; Milà M; Darnell A
Am J Kidney Dis; 1999 Aug; 34(2):273-8. PubMed ID: 10430974
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme insertion/deletion gene polymorphism in general population of west Azarbaijan, Iran.
Abdi Rad I; Bagheri M
Iran J Kidney Dis; 2011 Mar; 5(2):86-92. PubMed ID: 21368385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
